Screener
Prime Medicine PRME Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other income, net | 1,176 | 786 | 2,708 | 1,288 |
| Net loss attributable to common stockholders | $(42,109) | $(52,591) | $(91,231) | $(104,481) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.24) | $(0.41) | $(0.51) | $(0.81) |
| Weighted-average common shares outstanding, basic and diluted | 177,224,892 | 129,185,918 | 177,160,914 | 128,439,349 |
| Comprehensive loss: | ||||
| Net loss | $(42,109) | $(52,591) | $(91,231) | $(104,481) |
| Change in unrealized (loss) income on investments, net of tax | (8) | 5 | (91) | (11) |
| Comprehensive loss | $(42,117) | $(52,586) | $(91,322) | $(104,492) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's comprehensive income (loss), net of tax, attributable to parent?
- Prime Medicine (PRME) reported comprehensive income (loss), net of tax, attributable to parent of -$42.12M in Q2 2026.
- How has Prime Medicine's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Prime Medicine's comprehensive income (loss), net of tax, attributable to parent increased by 19.9% year-over-year, from -$52.59M to -$42.12M.
- What is the long-term trend for Prime Medicine's comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2022 to 2025), Prime Medicine's comprehensive income (loss), net of tax, attributable to parent has grown at a 18.1% compound annual growth rate (CAGR), from -$122.18M to -$201.06M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on investments. It provides a comprehensive view of the company's financial performance by including all recognized revenues, expenses, gains, and losses. This figure is a key indicator of the total economic impact on the company's net assets during a specific period.
Ask your AI about Prime Medicine's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude